Jennifer K. Simpson

Jennifer K. Simpson, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Delcath Systems, Inc., Panbela Therapeutics, Inc. and Cytrx Corp. Over a trading history stretching from 23 March 2012 to 30 January 2023, the count stands at 14 filings.

Every open-market trade on record is a purchase: 6 purchases worth €17k, and no sale. No amount is published for 2 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 7 share grants. 2023 to date brings 1 purchase and no sales.

Half of the purchases are above €2,967 and half below. 2 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The record was last updated on 1 February 2023 with an open-market purchase in Panbela Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.